- You have no items in your shopping cart
- Subtotal: $0.00
Fatima
Posted on
Study highlights potential of genomic tests for early stage prostate cancer
Source: News-Medical.Net
A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests – Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris – can help doctors make better decisions about how to treat patients with early stage prostate cancer.
A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests – Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris – can help doctors make better decisions about how to treat patients with early stage prostate… [2917 chars]